Veeda Clinical Research Ltd is one of the largest independent full-service clinical research Organization (CRO) in India. Veeda Clinical Research Limited is a Public incorporated on 23 April 2004. It is classified as Non-government company and is registered at Registrar of Companies, ROC Ahmedabad. Its authorized share capital is Rs. 36,44,06,800 and its paid up capital is Rs.13,97,17,006. It is inolved in Research and experimental development on natural sciences and engineering (NSE).
Veeda Clinical Share Price, Share Details as of March 31, 2026
Veeda Clinical Outstanding Shares: |
6,98,58,503 |
Face Value of Veeda Clinical Share |
Rs. 2 Per Equity Share |
ISIN of Veeda Clinical Share |
INE01HQ01026 |
Lot Size of Veeda Clinical Share |
100 |
Veeda Clinical Share Price |
Best In Industry |
PAN Number of Veeda Clinical |
AACCC3633Q |
GST Number of Veeda Clinical |
24AACCC3633Q1ZI |
Veeda Clinical CIN Number |
U73100GJ2004PLC044023 |
Veeda Clinical Registration Date |
23-April-2004 |
Category / Sub-Category of Veeda Clinical |
Company limited by shares/Non-Govt. Company |
Veeda Clinical Registered Office Address |
SHIVALIK PLAZA-A-,2nd FLOOR OPP AHMEDABAD MANAGEMENT ASSOCIATION AMB AWADI , AHMEDABAD, Gujarat, India - 380015 |
Veeda Clinical Registrar & Transfer Agent Address |
Link Intime India Pvt. Ltd. C‐101, 247 Park, LBS Marg, Vikroli (West)‐Mumbai 400083 |
|
Directors |
Post |
|
Mr. Nitin Deshmukh |
Independent Director |
|
Mr. Nirmal Bhatia |
CFO , Company Secretary |
|
Mr. Rakesh Bhartia |
Independent Director |
|
Mr. Binoy Gardi |
Managing Director, CEO |
|
Mr. Apurva Shah |
Additional Director |
|
Dr. Kiran Marthak |
Director |
|
Dr. S.N. Viaya Babu |
Director |
|
Mr. Vivek Chhachhi |
Director |
|
Mr. Vinayak Shenvi |
Nominee Director |
|
Ms Tanushree Agarwal |
Nominee Director |
|
Mr. David Paul |
Independent Director |
|
Mr Georgios Kouvatseas |
Nominee Director |
|
Name and Description of main products/services |
NIC Code of the product/service* |
% to the total turnover of the Company |
|
Research and experimental development on natural sciences and engineering (NSE). |
73100 |
100% |
Name of the Company | Holding/Subsidiary/Associate | % of shares held |
Bioneeds India Private Limited | Subsidiary | 87% |
Amthera Life Sciences Private Ltd | Step-down Subsidiary | 87% |
|
Category |
No. of Shares |
% of Shares held |
|
Promoters |
2,22,51,712 |
31.85% |
|
Public Shareholding |
4,76,06,791 |
68.15% |
|
Total |
6,98,58,503 |
100.00% |
Q. What
is the face value of Veeda Clinical Research Ltd shares?
Answer: The face value of Veeda Clinical Research Ltd shares is ₹2
per equity share.
Q. What
is the minimum lot size for buying Veeda Clinical Research shares through
WWIPL?
Answer: The minimum lot size is 100 shares, subject to market
availability.
Q. Why
should I buy Veeda Clinical Research shares through WWIPL?
Answer: WWIPL offers transparent pricing, verified transfers, secure
settlements, and dedicated support throughout the investment journey.
Q. What
does Veeda Clinical Research Ltd do?
Answer: Veeda Clinical Research is a Contract Research Organization
(CRO) that provides clinical research, bioequivalence studies,
bioavailability studies, clinical trials, and laboratory services to
pharmaceutical and biotechnology companies.
Q. Is
Veeda Clinical Research a pharmaceutical manufacturing company?
Answer: No. Veeda does not primarily manufacture drugs. It supports
pharmaceutical companies through research, testing, and clinical development
services.
Q. What
services does Veeda Clinical Research provide?
Answer: The company offers bioequivalence studies, bioavailability
studies, clinical trials, central laboratory services, analytical testing, and
regulatory support services.
Q. Who
are Veeda's customers?
Answer: Veeda serves pharmaceutical companies, biotechnology firms,
generic drug manufacturers, and healthcare companies seeking research and
development support.
Q. What
makes Veeda Clinical Research different from traditional pharma companies?
Answer: Instead of selling medicines, Veeda generates revenue by
providing research and clinical development services that help clients bring
products to market.
Q. Is
investing in Veeda Clinical Research a good idea?
Answer: Investors often evaluate Veeda based on growth in pharmaceutical
R&D spending, outsourcing trends, and increasing demand for CRO services.
Q. What
are the key growth drivers for Veeda Clinical Research?
Answer: Rising global clinical research outsourcing, increasing generic
drug development, regulatory requirements, and growth in biotechnology research
can support future growth.
Q. What
factors influence the valuation of Veeda Clinical Research shares?
Answer: Revenue growth, client additions, study volumes, operating margins,
capacity utilization, and profitability are key valuation drivers.
Q. Why do
investors track Veeda Clinical Research shares closely?
Answer: Many investors view Veeda as a play on the expanding global
pharmaceutical research outsourcing and CRO industry.
Q. What
are the risks of investing in Veeda Clinical Research shares?
Answer: Investors should consider client concentration, regulatory
compliance risks, project execution risks, competitive pressures, and liquidity
constraints associated with unlisted shares.
Q. What should investors evaluate before
investing in Veeda Clinical Research Ltd?
Answer: Investors should assess client diversification, revenue growth,
operating margins, research capabilities, regulatory track record, and
long-term industry demand.
